Neuro Advance Boston brings together leading neuro experts from industry and academia along with key members of the healthcare investment community to brainstorm about the most pressing issues facing neuro drug development. This is an invitation-only, intimate and off-the-record meeting with limited attendance to foster brainstorming and meaningful dialogue. Interactive panels feature CEOs, CMOs, CSOs, and Heads of Neuro from top biopharmaceutical companies in the neuro space, along with leading academics and healthcare investors discussing everything from gene therapy to advances in psychiatry to novel therapeutic approaches.

\’Neuro Advance Boston promises to be an energetic, innovative environment for cross-talk among leaders in the neuro research and investment communities — encouraging faster progress from lab to market.\’ — Betsy Nabel, President, Brigham and Women\’s Hospital

“Neuro Advance Boston brings together an absolutely stellar group ofscientists, clinical investigators, entrepreneurs and investors in a completely unrehearsed forum for a candid andvery enlightening discussion of the exciting and rapidly maturing field of neuroscience and the manyopportunities this science affords for creating innovative new treatments for many of humankind’s mostdevastating afflictions.\’ — Steve Paul, CEO, Voyager Therapeutics; Venture Partner, Third Rock Ventures; Former President, Lilly Research Laboratories